Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 11/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | CTSD | P07339 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28067312 | 0.98 | ALOX5 (0.61) | ALOX5CYP3A4TSHRPTGS2GAA | |
| SCHEMBL13042440 | 0.91 | ALOX5 (0.68) | ALOX5CYP3A4TSHRPTGS2GAA | |
| SCHEMBL11416924 | 0.83 | ALOX5 (0.65) | ALOX5CYP3A4TSHRPTGS2GAA | |
| SCHEMBL491040 | 0.83 | ALOX5 (0.70) | ALOX5CYP3A4TSHRPTGS2GAA | |
| SCHEMBL5455720 | 0.82 | GAA (0.61) | ALOX5CYP3A4GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL20711457 | 0.82 | ALOX5 (0.58) | ALOX5CYP3A4TSHRPTGS2GAA | |
| SCHEMBL5444741 | 0.82 | GAA (0.68) | ALOX5GAASMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL5451366 | 0.82 | PTGS2 (0.56) | ALOX5CYP3A4TSHRPTGS2GAA | |
| SCHEMBL1531488 | 0.81 | ALOX5 (0.72) | ALOX5CYP3A4TSHRPTGS2GAA | |
| SCHEMBL22026670 | 0.81 | ALOX5 (0.61) | ALOX5CYP3A4TSHRPTGS2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3720295-A2 | TRYPTOPHAN DERIVATIVES AS SWEETENERS | Chromocell Corporation (US) | 2020-10-14 | — | — | EP | disclosed |
| US-20200297015-A1 | TRYPTOPHAN DERIVATIVES AS SWEETENERS | CHROMOCELL CORPORATION (US) | 2020-09-24 | — | — | US | disclosed |
| WO-2019113443-A2 | TRYPTOPHAN DERIVATIVES AS SWEETENERS | CHROMOCELL CORPORATION (US) | 2019-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200297015-A1 | TRYPTOPHAN DERIVATIVES AS SWEETENERS | TPH1, TPH2, SLC6A4 | ALOX5 2324/4885CYP3A4 1836/4885TSHR 3275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.